Henrik Hasle

  1. 1993
  2. Koordinator for de nordiske lande for den prospektive EWOG-MDS undersøgelse (External organisation)

    Henrik Hasle (Member)

    1 Jun 1993 → …

    Activity: Membership typesMembership in committee, council, board

  3. 2001
  4. Myeloid malignancies in Down syndrome

    Henrik Hasle (Lecturer)

    25 Mar 2001

    Activity: Talk or presentation typesLecture and oral contribution

  5. 2002
  6. Formand for NOPHO AML-gruppen. Principal investigator af NOPHO-AML 2004 protokollen. (External organisation)

    Henrik Hasle (Member)

    1 Feb 2002 → …

    Activity: Membership typesMembership in committee, council, board

  7. 2004
  8. Dansk leukæmi/lymfom specialgruppe under DAPHO (External organisation)

    Henrik Hasle (Member)

    1 Jan 2004 → …

    Activity: Membership typesMembership in committee, council, board

  9. NOPHO-AML 2004 protokollen (External organisation)

    Henrik Hasle (Member)

    1 Jan 2004 → …

    Activity: Membership typesMembership in committee, council, board

  10. 2006
  11. Bestyrelsesmedlem af DAPHO (External organisation)

    Henrik Hasle (Member)

    1 Mar 2006 → …

    Activity: Membership typesMembership in committee, council, board

  12. Udvalg (External organisation)

    Henrik Hasle (Member)

    1 Aug 200612 Jan 2007

    Activity: Membership typesMembership in review committee

  13. 2007
  14. Formand for speciallægerådet i pædiatri i Region Midt. (External organisation)

    Henrik Hasle (Member)

    1 Jan 2007 → …

    Activity: Membership typesMembership in committee, council, board

  15. Specialerådet i pædiatri i Region Midt (External organisation)

    Henrik Hasle (Member)

    1 Jan 2007 → …

    Activity: Membership typesMembership in committee, council, board

  16. DAPHO (External organisation)

    Henrik Hasle (Member)

    1 Mar 2007 → …

    Activity: Membership typesMembership in committee, council, board

  17. 2008
  18. Myelodysplastic Syndrome

    Henrik Hasle (Lecturer)

    6 Mar 2008

    Activity: Talk or presentation typesLecture and oral contribution

  19. Bone Marrow Failure Syndromes

    Henrik Hasle (Lecturer)

    8 Apr 2008

    Activity: Talk or presentation typesLecture and oral contribution

  20. NOPHO (External organisation)

    Henrik Hasle (Member)

    14 May 2008 → …

    Activity: Membership typesMembership in committee, council, board

  21. Formand for NOPHO leukaemia lymphoma working group. (External organisation)

    Henrik Hasle (Member)

    1 Jun 2008 → …

    Activity: Membership typesMembership in committee, council, board

  22. AML - Fra tidlig død til langtidsoverlevere. En nordisk succeshistorie.

    Henrik Hasle (Lecturer)

    6 Jun 2008

    Activity: Talk or presentation typesLecture and oral contribution

  23. Dansk Hæmatologisk Selskabs Transplantationsudvalg (External organisation)

    Henrik Hasle (Member)

    1 Jul 2008 → …

    Activity: Membership typesMembership in committee, council, board

  24. 2009
  25. Pediatric Blood & Cancer (External organisation)

    Henrik Hasle (Member)

    2009 → …

    Activity: Membership typesMembership in board of company or public organisation

  26. Samtaler med alvorlig syke barn og deres foreldre.

    Henrik Hasle (Lecturer)

    5 Feb 2009

    Activity: Talk or presentation typesLecture and oral contribution

  27. AML in children. Indications for SCT in the Nordic countries. EBMT 35th annual meeting, Göteborg, Marts 30, 2009.

    Henrik Hasle (Lecturer)

    30 Mar 2009

    Activity: Talk or presentation typesLecture and oral contribution

  28. International summer school in pediatrics.

    Henrik Hasle (Organizer)

    29 Jun 200921 Aug 2009

    Activity: Participating in or organising an event typesParticipation in or organisation af a conference

  29. SCT in high-risk AML. Best of I-BFM-SG. SIOP annual meeting.

    Henrik Hasle (Lecturer)

    9 Oct 2009

    Activity: Talk or presentation typesLecture and oral contribution

  30. Chairman for sessionen Bone marrow failure and childhood MDS.

    Henrik Hasle (Lecturer)

    22 Oct 2009

    Activity: Talk or presentation typesLecture and oral contribution

  31. Diagnosis and classification of childhood MDS. ESO - Euroconference on myelodysplastic syndromes.

    Henrik Hasle (Lecturer)

    22 Oct 2009

    Activity: Talk or presentation typesLecture and oral contribution

  32. Curative therapy of childhood MDS and JMML. ESO - Euroconference on myelodysplastic syndromes.

    Henrik Hasle (Lecturer)

    24 Oct 2009

    Activity: Talk or presentation typesLecture and oral contribution

  33. U-kursus i hæmatologi/onkologi for pædiatere

    Henrik Hasle (Participant)

    10 Nov 2009 → …

    Activity: Participating in or organising an event typesParticipation in or organisation af a conference

  34. 2010
  35. NFCG meeting

    Henrik Hasle (Invited speaker)

    4 Feb 2010

    Activity: Talk or presentation typesLecture and oral contribution

  36. Mumbai Haematology Group Annual Meeting

    Henrik Hasle (Invited speaker)

    7 Mar 2010

    Activity: Talk or presentation typesLecture and oral contribution

  37. Mumbai Haematology Group Annual Meeting

    Henrik Hasle (Invited speaker)

    7 Mar 2010

    Activity: Talk or presentation typesLecture and oral contribution

  38. 7th meeting of EBMT

    Henrik Hasle (Invited speaker)

    2 Jun 2010

    Activity: Talk or presentation typesLecture and oral contribution

  39. Controversies in indications

    Henrik Hasle (Advisor)

    2 Jun 2010

    Activity: Consultancy typesConsultancy

  40. Annual meeting of the international BFM study

    Henrik Hasle (Invited speaker)

    3 Oct 2010

    Activity: Talk or presentation typesLecture and oral contribution

  41. Annual meeting of the international BFM study group

    Henrik Hasle (Invited speaker)

    3 Oct 2010

    Activity: Talk or presentation typesLecture and oral contribution

  42. MRD in AML: Annual meeting of the International BFM study group.

    Henrik Hasle (Participant)

    3 Oct 2010

    Activity: Other activity typesOther

  43. AML: New approaches in diagnostics - new targets for therapy.

    Henrik Hasle (Participant)

    5 Oct 2010

    Activity: Other activity typesOther

  44. 2011
  45. Late effect of cancer at a young age.: Registrybased studies of the health of cancer patients and their offspring.

    Henrik Hasle (Participant)

    4 Mar 2011

    Activity: Other activity typesOther (prizes, external teaching and other activities) - External teaching and subject coordination

  46. Refractory cytopenia in children. Diagnosis and management.

    Henrik Hasle (Lecturer)

    24 Mar 2011

    Activity: Talk or presentation typesLecture and oral contribution

  47. JMML

    Henrik Hasle (Lecturer)

    25 Mar 2011

    Activity: Talk or presentation typesLecture and oral contribution

  48. Advanced MDS in children.: Diagnosis and management.

    Henrik Hasle (Lecturer)

    26 Mar 2011

    Activity: Talk or presentation typesLecture and oral contribution

  49. NOPHO AML teatment and outcome.

    Henrik Hasle (Lecturer)

    14 Apr 2011

    Activity: Talk or presentation typesLecture and oral contribution

  50. Diagnosis and management of children with MDS and JMML.

    Henrik Hasle (Lecturer)

    10 Jun 2011

    Activity: Talk or presentation typesLecture and oral contribution

  51. SCT in children with AML indications and results.

    Henrik Hasle (Lecturer)

    15 Oct 2011

    Activity: Talk or presentation typesLecture and oral contribution

  52. AML hos børn

    Henrik Hasle (Lecturer)

    26 Oct 2011

    Activity: Talk or presentation typesLecture and oral contribution

  53. The effects of a controlled family nurse directed intervention program for parents hospitalized with children undergoing allogenic haematopoietic stem cell transplantation.

    Henrik Hasle (Participant)

    8 Nov 2011

    Activity: Other activity typesOther (prizes, external teaching and other activities) - External teaching and subject coordination

  54. Venous and arterial thromboembolism in children and adolescents in Denmark 1994-2006.

    Henrik Hasle (Participant)

    11 Nov 2011

    Activity: Other activity typesOther (prizes, external teaching and other activities) - External teaching and subject coordination

  55. 2012
  56. European Society of Paediatric Oncology (SIOPE) (External organisation)

    Henrik Hasle (Member)

    2012 → …

    Activity: Membership typesMembership in board of company or public organisation

  57. AML treatment and complications: 2nd vietnamese course in pediatric oncology.

    Henrik Hasle (Lecturer)

    9 Feb 2012

    Activity: Talk or presentation typesLecture and oral contribution

  58. Hyperleukocytosis-Tumor lysis syndrome: 2nd Vietnamese course in pediatric oncology.

    Henrik Hasle (Lecturer)

    9 Feb 2012

    Activity: Talk or presentation typesLecture and oral contribution

  59. NOPHO-AML current status

    Henrik Hasle (Lecturer)

    18 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  60. Vidaza program in myeloid leukemia.

    Henrik Hasle (Lecturer)

    18 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  61. ALL case with a leukemoid reaction/MDS 16 months before ALL.

    Henrik Hasle (Lecturer)

    21 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  62. Pre-emptive treatment of relapsed in AML with azacitidine.

    Henrik Hasle (Lecturer)

    21 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  63. Early detection of molecular relapse in AML and possible consequences.: Childhood Leukemia Symposium

    Henrik Hasle (Lecturer)

    23 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  64. International Standards for diagnostics in AML in 2012.: Childhood Leukemia Symposium

    Henrik Hasle (Lecturer)

    23 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  65. Early detection of molecular relapse in pediatric AML.

    Henrik Hasle (Lecturer)

    7 Dec 2012

    Activity: Talk or presentation typesLecture and oral contribution

  66. 2013
  67. American Society of Hematology; ICM - ASH (External organisation)

    Henrik Hasle (Member)

    2013 → …

    Activity: Membership typesMembership in committee, council, board

  68. The molecular heterogeneity of MML rearranged pediatric AML.

    Henrik Hasle (Participant)

    26 Jun 2013

    Activity: Other activity typesOther

  69. Mental late effect in childhood cancer survivors and their siblings.

    Henrik Hasle (Participant)

    1 Nov 2013

    Activity: Other activity typesOther

  70. 2015
  71. Aarhus University (External organisation)

    Henrik Hasle (Member)

    22 Jun 2015

    Activity: Membership typesMembership in review committee

  72. Aarhus University (External organisation)

    Henrik Hasle (Member)

    30 Oct 2015

    Activity: Membership typesMembership in review committee

  73. 2016
  74. I-BFM SG The International BFM Study Group (External organisation)

    Henrik Hasle (Chairman)

    2016 → …

    Activity: Membership typesMembership in committee, council, board

  75. Central nervous system involvement in childhood acute lymphoblastic leukemia

    Henrik Hasle (Participant)

    13 Dec 2016

    Activity: Other activity typesOther

  76. 2019
  77. Individualized treatment for patients with JMML

    Henrik Hasle (Lecturer)

    5 Apr 2019

    Activity: Talk or presentation typesLecture and oral contribution

  78. Diagnostics and classification of patients with MDS and myeloproliferative disorders

    Henrik Hasle (Lecturer)

    6 Apr 2019

    Activity: Talk or presentation typesLecture and oral contribution

  79. Overview of childhood AML. Paediatric Strategy Forum for Medicinal Product Development for AML in Children and Adolescents

    Henrik Hasle (Lecturer)

    11 Apr 2019

    Activity: Talk or presentation typesLecture and oral contribution

  80. I-BFM-AML-SG biannual meeting

    Henrik Hasle (Organizer)

    20 May 2019

    Activity: Participating in or organising an event typesParticipation in or organisation of workshop, seminar or course

  81. Bedømmelse af PhD afhandling. (Event)

    Henrik Hasle (Member)

    3 Jul 2019

    Activity: Membership typesMembership in review committee

  82. Bedømmelse af PhD afhandling. (Event)

    Henrik Hasle (Member)

    18 Sep 2019

    Activity: Membership typesMembership in review committee

  83. Unique pattern of leukemia in Down syndrome. Disparities and Outcomes in Acute Leukemia.

    Henrik Hasle (Lecturer)

    4 Nov 2019

    Activity: Talk or presentation typesLecture and oral contribution

  84. I-BFM-AML-SG biannual meeting

    Henrik Hasle (Organizer)

    7 Dec 2019

    Activity: Participating in or organising an event typesParticipation in or organisation of workshop, seminar or course

  85. 2020
  86. Department of Clinical Medicine - Department of Paediatrics (Organisational unit)

    Henrik Hasle (Member)

    13 Nov 2020

    Activity: Membership typesMembership in review committee